It would be of some interest to know how many patients are being treated for epilepsy at any one moment, the incidence of epilepsy, very broadly defined, in Great Britain usually being considered to be about 250,000 persons. Through the kind co-operation of the Leeds Executive Council a group of general practitioners was circularized and information obtained relating to a population of about 300,000. 800 epileptic patients were reported to be under treatment, an incidence of 2-5 patients per 1,000 population. This suggests that the number of epileptics under treatment in Great Britian (population approx. 50,000,000) is about 125,000, which is perhaps only half of all epileptics.
Spongy hypertrophy of the gums is usually a late complication and though superficially this may resemble scurvy it is probably unrelated to deficiency of ascorbic acid (Hawkins and Meynell, 1956) . Symonds (1950) estimated the frequency of this toxic manifestation to be in the region of 15 % but my impression is that the incidence is less than that. It may be that a lower figure has resulted from improvement in dental hygiene in recent years, since it has been claimed by Nattrass (1949) that hypertrophy may be associated with dental sepsis; in my experience, however, this is certainly not always true. Gum hypertrophy is reversible and may largely result from cedema; it rarely if ever occurs after the administration of other hydantoins and for this reason Mesontoin may be substituted for sodium phenytoin when gum hypertrophy proves troublesome.
Perhaps the most interesting late toxic effect, and the last to be recognized, is a megaloblastic anumia. The first example of this was described by Badenoch in 1954 . In a recent survey of the subject Gydell (1957) reviewed the problem of megaloblastic aniemia in patients being treated with diphenylhydantoin and primidone; 3 personal cases are described and 14 others mentioned from the literature between 1954 and 1957. All 17 were taking one of the hydantoins with the exception of 3 who were taking primidone alone. The duration of treatment had varied from thirteen years to nine months and the ages of the patients from 17 to 52, 12 being females. It was striking that the 14 quoted from the literature all came from England. What interests me still more is that I find that I first recognized this condition, without appreciating its importance, in 1948.
A woman of 28 had suffered from major epilepsy since the age of 3. For eleven years she had been taking sodium phenytoin grains 4j and phenobarbitone grains I j daily; at one point Mesontoin was substituted for phenytoin because of gum hypertrophy but because of drowsiness the former treatment was resumed. One month before admission to hospital in 1948 she had complained of increasing lassitude. She was found to be anmmic, with Hb 58°/, R.B.C. 2,900,000 and C.I. 1 0; a blood film showed macrocytosis, anisocytosis and poikilocytosis, the reticulocytes being less than 1 %; the sternal marrow was actively megaloblastic. The gastric juice contained free hydrochloric acid and the split and unsplit fecal fats were normal. Treatment with Anahlmin 4 ml. intramuscularly every day was without effect. Folic acid 30 mg. by mouth daily was followed by a reticulocyte response and both the peripheral blood and sternal marrow were rapidly restored to normal. Phenytoin had been withdrawn when the results of gastric analysis indicated that we were not looking at pernicious anemia but six months after leaving hospital phenytoin treatment was resumed and has been maintained, without folic acid, up to the present time without any hematological relapse.
Since that time I have had three other examples of anaemia of a similar character resulting from phenytoin, though one of these has also received primidone, and my experience adds nothing, except numbers, to that of Gydell and others (Hawkins and Meynell, 1954, 1956; Chalmers and Boheimer, 1954; Rhind and Varadi, 1954; Webster, 1954; Berlyne et al., 1955; Ryan and Forshaw, 1955) . In a few of these recorded examples extensive investigation has shown that the serum B12 level and the absorption of folic acid were normal; all have responded to folic acid by mouth and only four to vitamin B12 by injection, though in the case of two of the latter the withdrawal of phenytoin may have been responsible for the improvement (Webster, 1954; Ryan and Forshaw, 1955) whilst one other (Chalmers and Boheimer, 1954) may have had coincidental pernicious anaemia.
Girdwood and Lenman (1956) and Girdwood (1956) described a similar anaemia attributable to primidone. They pointed out that phenytoin, primidone and phenobarbitone all have in common with folic acid a pyrimidine ring and they suggested that drugs with this structure might act as competitive inhibitors for some enzyme system involving folic acid as a co-factor. It is therefore important that Hobson et al. (1956) have described a patient who developed a megaloblastic anaemia attributable to large quantities of the two barbiturates Amytal (amylobarbitone) and Seconal (quinalbarbitone). In addition, Hawkins and Meynell in 1956 surveyed 159 epileptic patients from a colony and found that only one had a frank megaloblastic anemia but 36 % showed the mean corpuscular volume increased to between 94 and 114 cu.,u; the sternal marrow was megaloblastic in 5 and probably so in 1 other. The highest incidence of macrocytosis occurred in those taking phenytoin and phenobarbitone (45°) but when either phenobarbitone or phenytoin alone had been taken the figure was still in the region of 30 %. Since reading their paper I have been carrying out routine blood counts on all patients taking these drugs but my figures at the moment are not significant.
The bromides.-It may cause some astonishment that the bromides should be invoked as a major cause of intoxication in the year 1957 but there is little doubt that many examples of bromism are overlooked as was emphasized by Spence (1957) . This condition has been proved in 2% of epileptics seen in private practice though it amounted to less than 0-7% of hospital patients, many of whom were seen by doctors who did not entertain the likelihood of bromism and had in all probability never recognized an example. I have shown elsewhere (Garland and Parsonage, 1951) Sharpe (1954) have reported acute confusional psychosis, with paranoid features, as a complication of primidone therapy. This is undoubtedly a valid observation but the advent of a psychopathy may not always be attributable to primidone alone. There is a high incidence of psychiatric deviation in patients with lesions of the temporal lobe, with or without epilepsy, and a fortuitous association in such patients treated with primidone must be expected. Hill and Falconer (1953) described 13 patients with epilepsy and psychopathy and in 11 of these there was EEG evidence of a focus in one temporal lobe. A second factor to consider is the phenomenon of convulsion dependence. It has been recognized for some time that psychotics who have occasional fits may obtain benefit from electric convulsant therapy and it is not uncommon to see pre-ictal irritability and tension relieved by the advent of a fit. Under these circumstances the suppression of fits may lead to a worsening of the mental state irrespective of the nature of the drug employed. However, bearing these considerations in mind, a few patients are totally unable to take primidone even in homceopathic doses. One patient, a woman of 22, had suffered from major convulsions, often with rotation of the head and eyes to the right, since the age of 3. She had been treated with a number of drugs including Mesontoin, phenytoin, phenobarbitone and phemitone, with a very inadequate control of her fits. EEG showed a widespread abnormality without focal features and all other investigations, including air encephalography, were normal. She was given a single dose of primidone 0-25 gram and within a matter of hours developed a confusional psychosis with paranoid delusions; this resolved in thirty-six hours and she remained mentally normal until a second dose of 0-125 gram of primidone was administered, when the previous experience was repeated. In this case the time relationship made it clear that the psychopathy had been provoked directly by the drug. However, after a year in which she had no primidone she became permanently deluded and is now a certified psychotic. One other patient, also a young woman, developed a similar psychopathy with primidone which was not related to fit-suppression.
Many patients become very drowsy when a barbiturate is given with primidone and there seems to be a synergistic effect between these drugs in tlhis respect. Skin rashes of morbilliform type have been reported by Whitty (1953) and Briggs and Tucker (1954) but they are uncommon. Acute primidone poisoning in a child has been reported by Morley and Wynne (1957) , the child having swallowed at least fifty tablets. An interesting feature of this case was the appearance of crystalluria and recovery of consciousness was accompanied by temporary ataxia.
The diones.-The strange symptom of visual "glistering", was first described by Lennox in 1947, affecting about 2% of epileptics treated with troxidone (Tridione). This seems to be peculiar to troxidone and when troublesome may be relieved immediately by changing to another dione. It is exceptionally rare in children under the age of 6, perhaps because of their inability to describe the symptom. Another occasional complication is the appearance of acneiform papules over the forehead and face, and more rarely a generalized morbilliform eruption (Lennox, 1947) .
By far the most important drawback to the use of the diones is their effect on the bonemarrow. Two distinct forms of blood dyscrasia occur. The first, which is not uncommon, consists of a slow downward drift of the neutrophil count, sometimes associated with a mild increase in the total eosinophils and lymphocytes (Davis and Lennox, 1947; Greaves, 1946; Briggs and Emery, 1949) . This, provided it is detected in time by serial blood counts, is not dangerous and the normal white cell count is restored when diones are withdrawn. The second, which fortunately is rare and which I have not yet seen, is the sudden development of an aplastic anaemia with a rapid diminution of the circulating red cells, polymorphonuclear white cells and platelets (Harrison et al., 1946; Mackay and Gottstein, 1946; Braithwaite, 1948; Forster et al., 1949) . I believe that all the recorded cases of aplastic anemia have died of secondary infection and multiple hkmorrhages, together with one example of exfoliative dermatitis, and energetic therapy with hiematinics, transfusion, antibiotics and the withdrawal of diones seems to be of no avail. Moreover, the condition develops too rapidly for serial blood counts to be of any value. Although only a few examples of this kind have been reported the hopeless prognosis has naturally served as a deterrent to those who would otherwise use the diones. However, I feel that in view of the large number of patients who have taken diones without ill-effect the dangers have perhaps been overemphasized. Often patients with petit mal may be treated with other drugs such as Diamox or amphetamine with a measure of success, and other mild cases frequently require no treatment at all, but when fits interfere with the education of a child or later with employment it may be essential to effect control with one of the dione group.
Some authorities (Lennox, 1945; Whitty, 1949; Symonds, 1950) Bromides.-In psychiatric practice most of the indications for which bromide is givenand these include states of acute grief and agitation on the one hand, and chronic disturbances of sleep rhythm on the other-are likely to be made worse rather than better, if the administration of this drug is continued for any length of time. This is particularly true when it is given to old people; and I would endorse a categorical veto on the exhibition of bromide to anyone over the age of 60, for any purpose whatever.
At the Maudsley Hospital we used to make serum bromide estimations as a routine on all patients admitted to the hospital, regarding a level above 200 mg. % as potentially toxic. Certainly, concentrations at and above this level can produce a state of confused drowsy irritability by day and disturbed paranoid and hallucinatory alarm and apprehension at night, in just those old people whose early senile dementing changes may have led to the administration of what was believed to be a safe and mild sedative over a period of several weeks.
Barbiturates.-Another stand-by whose use in psychiatry threatens to be equally abused is phenobarbitone. My own view is that there are only two really justifiable indications for phenobarbitone in psychiatric practice; the symptomatic alleviation of anxiety by small doses, regularly spaced; and the selected exhibition of a single 1 grain dose at 9 p.m. every evening for a month, as a trial therapeutic measure in the control of migraine, when this is allied to persistent emotional or environmental tension. It is only fair to add that this latter indication is borrowed from what was standard practice at the National Hospital, Queen's Square, when I was a registrar there.
All other occasions on which phenobarbitone is apt to be prescribed would probably be better met by an exhibition of other drugs. In particular, phenobarbitone should be rigorously avoided in all cases where there is an element of depression, since it undoubtedly tends to make depression worse, and can occasionally exacerbate it to the point of suicidal intensity. Quick-acting barbiturates are of course extremely useful in psychiatric practice, and are also reasonably safe, provided that they are not prescribed in undue bulk. Their chief toxic effects include:
(1) The risk of addiction, never to be overlooked, since addiction to barbiturate is by now probably the most common form of dependence on drugs in Western civilization.
(2) The additive effect when barbiturates are taken at the same time as alcohol; this has been suggested as a potentiating or synergistic effect, and has on occasion proved fatal when the dosage of barbiturate has not exceeded 9 grains of Sodium Amytal, and of alcohol, two large gins.
(3) Disturbance of glucose metabolism, both in the direction of hypo-and hyper-glycaemia, with a concomitant disturbance of vitamin B metabolism; both of which can be corrected by giving large doses of vitamin B when any barbiturates are prescribed for any length of time.
Amphetamine derivatives.-The wide use of Benzedrine, Dexedrine, and other amphetamine derivatives has made most of us familiar with the common clinical toxic effects which these very useful preparations can produce. They include anorexia of pathological degree, a tendency to hypertension, and once again the risk of addiction. This latter is perhaps less well recognized than the corresponding risk with barbiturates, but may not be much less common. One patient who was taking between 500-700 mg. of Dexedrine every day developed this addiction after being successfully weaned from alcohol, to which he had formerly been addicted, and put on to Dexedrine by his family doctor. Curiously enough, the only untoward symptom which this colossal dependence seemed to produce was a spontaneous tendency to fall asleep if he was without the drug for more than an hour or two.
However, there are other and far more ominous toxic effects which may be observed from time to time. Acute confusion and disorientation can occur when large doses of Dexedrine are combined with alcohol in purely social proportions; and Dr. P. H. Connell (1955) of the Maudsley Hospital has made some extremely interesting observations on acute psychotic episodes arising in the course of Dexedrine addiction and overdosage. Our own experience of toxic psychoses of this kind at Guy's has included 3 cases of acute paranoid delusions and hallucinations, with a marked strain of outright terror, and a constant urge on the part of the patient to escape from the delusional and hallucinatory pursuers. It is of some interest that 2 of these 3 cases were doctors' wives, and the third was a nursing sister. Psychotic reactions of this kind tend to settle down very rapidly once the drug is completely withdrawn, but produce sufficient disturbance during the withdrawal phase to require expert supervision, preferably in hospital.
The tranquillizers.-The number and complexity of drugs recently put on the market with the general object of producing varying degrees of subjective calmness, tranquillity, and detachment from sources of emotional stress, whether endogenous or exogenous, but without producing drowsiness or sedation in normal dosage, is legion. We have tried most of them in my Department, and while it would be invidious to mention those which appear to have no beneficial action whatever, and to produce in fact nothing but toxic side-effects, it may be helpful to mention some of the more generally useful preparations, whose toxic effects are usually avoidable provided effective supervision is maintained over dosage. These include: (1) Largactil (chlorpromazine), Notensil (acetyl promazine), Sparine (promazine)-all phenothiazine derivatives.
(2) Rauwolfia, and associated alkaloids, including reserpine and Rauwolfia serpentina. I shall consider mainly some less well-known toxic effects of certain barbiturates, and the principal effects of the most recently introduced central depressants, the tranquillizers of various kinds. The relation between barbiturates and porphyria has often been put forward but never well supported, and it has been suggested that there is no connexion, or that barbiturates are capable of precipitating attacks in persons who were in any case porphyrics or that some cases of porphyria were a consequence of unusual sensitivity to barbiturates. Experiments in animals have generally yielded negative results, but recently Goldberg (1954) has shown that certain barbiturates are particularly potent in promoting the excretion of coproporphyrin and uroporphyrin in rabbits and that the chemical structure of the individual barbiturate is important in this context. Activity is much greater in barbiturates containing an allyl group, as in quinalbarbitone (Seconal) and allylisopropylbarbituric acid (Alurate), and still greater when two allyl groups are present, as in allobarbitone (Dial). This observation brings the effect into line with the porphyria which may be precipitated by the hypnotic Sedormid, also an allyl compound, but it does not lead to any correlation between activity on the nervous system and porphyrin metabolism, because allylisopropylacetamide is as potent as Sedormid and allobarbitone in disturbing porphyrin metabolism, but is devoid of hypnotic activity. The available evidence suggests that the excess porphyrin is produced in the liver and that the effect is in no way neurotoxic.
Another toxic effect, both of barbiturates and of most of the tranquillizers, is a drug rash. Skin eruptions of various kinds have been reported after chlorpromazine (Lehmann and Hanrahan, 1954; Lomas et al., 1955) , reserpine (Sariver-Foner, 1956 ), meprobamate (Selling, 1955; West and Fonseca, 1956) , mephenesin (Wolf and Pinsky, 1954) , and even methylpentynol (de Lamater, 1952) . The incidence of such rashes is usually between 2 and 3%, and they commonly appear at the beginning of medication. It seems important to note that they have also been observed after administration of placebo tablets, containing such a pharmacologically innocent material as lactose. Thus Wolf and Pinsky (1954) treated 31 patients with various kinds of anxiety state alternately with lactose and mephenesin: the trial was a properly conducted double-blind in that neither physician nor patient knew when the dummy was being given, and it yielded three toxic reactions including an angioneurotic cedema and a skin rash, diagnosed as a characteristic dermatitis medicamentosa, both precipitated by the administration of lactose. The series is rather small, and more observations of this sort are most desirable, but it suggests that, particularly with the kind of patients to whom sedatives are commonly administered, caution is desirable in the interpretation of symptoms suggestive of a toxic origin. It does not, of course, mean that skin eruptions occurring after any of these drugs are never directly related to the drug administered, but it limits the value of estimates of the incidence of toxic effects, since they will be much affected by the kind of patient being treated. Just as the therapeutic value of a drug requires to be demonstrated by a blind therapeutic trial, unless the effect is very striking, so estimates of the incidence of toxic effects are liable to be misleading except when they are based on observations properly controlled by the administration of dummy tablets to a sufficient proportion of the group being treated.
All these reactions to barbiturates, however, make a very small contribution to the total loss of life caused by these drugs, which accounted for over 500 deaths in 1954 (Brooke, 1956) and perhaps ten times as many hospital admissions (Locket, 1956) . Most of these deaths and intoxications were suicidal, but they were only possible because sufficient amounts of barbiturate had been made available on prescription to these patients. It seems impossible to assess whether all or any of these deaths would have occurred by other means if barbiturates had not been available to the persons concerned, but it is reasonable to suppose that the ease of this method of suicide contributed to the incidence, and to regard less liberal prescribing as desirable. In some of these cases, ethyl alcohol has been regarded as a contributory agent, and the term potentiation commonly appears. It is convenient to distinguish between potentiation and simple addition or summation of the actions of two drugs. If the dose of one drug necessary to produce a given effect is A, and the corresponding dose of another is B, and if the effect can be produced by a total dosage less than JA+ IB, then potentiation has occurred; if the effect is just produced by iA+IB, the drugs are additive, and if more than IA+IB is required, the drugs are to some extent antagonizing each other. Alcohol, like barbiturates, depresses the respiratory centre and in acute poisoning by any of these drugs death occurs from respiratory failure. There is no evidence that the agents either potentiate or antagonize each other, and half a lethal dose of alcohol and half a lethal dose of barbiturate are together lethal (Ramsey and Haag, 1946) . Reported cases of death occurring after ordinary therapeutic doses or not greatly excessive doses of a barbiturate have generally been accompanied by very high concentrations of alcohol in the blood (Fisher et al., 1948) .
As alternatives to the barbiturates for some purposes there are the so-called tranquillizers of various kinds. Their appearance has coincided with much activity in studying the pharmacology and biochemistry of the central nervous system, and new facts are being discovered so rapidly that it is not easy to make a coherent picture about them. At present, the tranquillizers are a very unhomogeneous group of substances which differ in potency, and chemically, and pharmacologically. The most potent, and most complicated, are reserpine and chlorpromazine. Both, and particularly chlorpromazine, have a variety of dissimilar actions, mainly in the central nervous system. It is unusual for a drug to have fundamentally more than one or two actions, and this suggests that they act on some mechanism common to a variety of nervous pathways.
In Methylpentynol (Oblivon) is one of the higher alcohols, and its effects are much less specific and are closest to those of ethyl alcohol and the barbiturates. Probably it acts in the same way as ethyl alcohol, but it is more rapidly metabolized and small differences between it and ethanol in the rate at which the concentration rises and falls in different parts of the body may be responsible for the appearance of different symptoms. In view of its usually rapid inactivation it is curious that many of the toxic effects which have been described (May and Ebaugh, 1953; Marley and Chambers, 1956 ) have followed the intake of only moderately large doses (1-2 grams per day) for a few days. The symptoms are not very specific: Marley and Chambers describe nystagmus, diplopia, ptosis and muscular incoordination, and variation in mood, usually towards depression: the symptoms abate fairly rapidly on withdrawal of the drug. At the normal rate of inactivation, cumulation of methylpentynol would not be expected in these conditions, and estimations of its concentration in the blood when these symptoms occur would be useful in understanding how they arise.
The question arises as to whether harm may result from prolonged use of these drugs, particularly when they are self-administered. The matter has received considerable public attention because some of the tranquillizers have been, or are, freely available and are evidently being consumed somewhat indiscriminately. It is very difficult to decide what harm is accruing in this way. So far little direct physical damage has been reported, and the problem of control would be simpler if all the tranquillizers caused agranulocytosis as often as does amidopyrine: but the passage of time may bring more evidence of this sort. Some disturbances of behaviour have been reported, such as driving cars into buses, or motor cycles into walls or submitting to seduction by strangers (Pratap, 1956 ), but controlled studies are particularly lacking in these circumstances and it is very uncertain whether some of the events described would not have occurred without the intervention of a tranquillizer. On the face of the evidence behavioural disturbances are no worse than those produced by alcohol, and alcohol is almost certainly responsible for more road accidents than all the tranquillizers put together. And the possibility of dependence, habituation or addiction is an unassessed risk. Addiction has been reported, for instance, to meprobamate (Lemere, 1955) but mostly in patients who were receiving treatment for previous addiction to alcohol. The risk of addiction depends on the drug and the patient: the milder the central depressant action of the drug, the more important is the personality of the patient, and drugs which have no more powerful action than one of producing tranquillity are likely to be addictable only to a limited section of the community. Whether these risks taken together are great enough to make more stringent control appropriate remains a somewhat debatable question, but there is a good deal to be said against any encouragement of their wider consumption.
